X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43387) 43387
Publication (3338) 3338
Book Review (559) 559
Newspaper Article (499) 499
Book Chapter (172) 172
Newsletter (135) 135
Magazine Article (76) 76
Dissertation (37) 37
Conference Proceeding (32) 32
Book / eBook (29) 29
Trade Publication Article (18) 18
Streaming Video (10) 10
Web Resource (8) 8
Transcript (6) 6
Data Set (5) 5
Presentation (4) 4
Paper (3) 3
Report (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35755) 35755
male (20784) 20784
female (20134) 20134
index medicus (18756) 18756
adult (16011) 16011
transplantation (14580) 14580
middle aged (13767) 13767
hematology (12748) 12748
oncology (9968) 9968
adolescent (8972) 8972
stem cells (8240) 8240
bone marrow (8118) 8118
animals (7918) 7918
immunology (7770) 7770
bone-marrow-transplantation (7435) 7435
treatment outcome (6970) 6970
child (6821) 6821
aged (6686) 6686
bone marrow transplantation - adverse effects (6438) 6438
bone marrow transplantation (5985) 5985
transplantation, homologous (5282) 5282
hematopoietic stem cell transplantation - adverse effects (4921) 4921
risk factors (4715) 4715
retrospective studies (4589) 4589
surgery (4345) 4345
child, preschool (4286) 4286
hematopoietic stem cells (4077) 4077
care and treatment (3996) 3996
health aspects (3996) 3996
chemotherapy (3884) 3884
bone-marrow transplantation (3863) 3863
therapy (3614) 3614
cancer (3594) 3594
research (3577) 3577
leukemia (3403) 3403
follow-up studies (3400) 3400
bone-marrow (3357) 3357
young adult (3270) 3270
mice (3235) 3235
transplantation, autologous (3120) 3120
analysis (3082) 3082
hematopoietic stem cell transplantation (3007) 3007
stem-cell transplantation (2999) 2999
transplants & implants (2903) 2903
time factors (2878) 2878
stem cell transplantation (2856) 2856
versus-host-disease (2716) 2716
infant (2690) 2690
graft vs host disease - etiology (2669) 2669
children (2609) 2609
medicine & public health (2593) 2593
disease (2584) 2584
orthopedics (2522) 2522
prognosis (2449) 2449
medicine, research & experimental (2387) 2387
antineoplastic combined chemotherapy protocols - therapeutic use (2358) 2358
pediatrics (2241) 2241
cell biology (2210) 2210
combined modality therapy (2202) 2202
patients (2158) 2158
prospective studies (2149) 2149
medicine (2106) 2106
hematopoietic stem cell transplantation - methods (2065) 2065
recipients (2010) 2010
mortality (1951) 1951
survival analysis (1936) 1936
recurrence (1871) 1871
blood (1839) 1839
article (1834) 1834
diagnosis (1824) 1824
graft vs host disease - prevention & control (1816) 1816
antineoplastic combined chemotherapy protocols - adverse effects (1815) 1815
survival (1785) 1785
survival rate (1710) 1710
hematology, oncology and palliative medicine (1634) 1634
clinical trials (1631) 1631
acute disease (1625) 1625
colony-stimulating factor (1616) 1616
bone transplantation - methods (1595) 1595
bone transplantation (1565) 1565
medicine, general & internal (1549) 1549
transplantation conditioning - methods (1544) 1544
medical research (1529) 1529
regeneration (1521) 1521
incidence (1514) 1514
progenitor cells (1498) 1498
disease-free survival (1497) 1497
abridged index medicus (1459) 1459
complications and side effects (1450) 1450
antineoplastic agents - adverse effects (1447) 1447
rats (1431) 1431
usage (1412) 1412
in-vitro (1409) 1409
immunosuppressive agents - therapeutic use (1408) 1408
risk (1383) 1383
complications (1369) 1369
studies (1369) 1369
cell & tissue engineering (1368) 1368
disease models, animal (1346) 1346
acute myeloid-leukemia (1345) 1345
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Online Resources - Online (8) 8
Dentistry (Harry R Abbott) - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Royal Ontario Museum - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43011) 43011
French (345) 345
German (278) 278
Japanese (250) 250
Spanish (149) 149
Chinese (147) 147
Russian (114) 114
Italian (62) 62
Polish (56) 56
Portuguese (26) 26
Czech (23) 23
Hungarian (19) 19
Dutch (17) 17
Norwegian (14) 14
Danish (12) 12
Swedish (12) 12
Croatian (10) 10
Turkish (9) 9
Korean (8) 8
Hebrew (6) 6
Finnish (4) 4
Bulgarian (3) 3
Arabic (2) 2
Serbian (2) 2
Lithuanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bone Marrow Transplantation, ISSN 0268-3369, 01/2011, Volume 46, Issue 1, pp. 98 - 104
Dyskeratosis congenita (DC) is characterized by reticular skin pigmentation, oral leukoplakia and abnormal nails. Patients with DC have very short telomeres... 
hematopoietic cell transplantation | dyskeratosis congenita | reduced-intensity conditioning regimen | ALEMTUZUMAB | CYCLOPHOSPHAMIDE | BONE-MARROW-TRANSPLANTATION | ANTITHYMOCYTE GLOBULIN | IMMUNOLOGY | FANCONI-ANEMIA | FLUDARABINE | TRANSPLANTATION | CORD BLOOD TRANSPLANTATION | ONCOLOGY | PATIENT | HEMATOLOGY | APLASTIC-ANEMIA | MELPHALAN | Antibodies, Neoplasm - therapeutic use | Cyclophosphamide - administration & dosage | Peripheral Blood Stem Cell Transplantation - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Whole-Body Irradiation - adverse effects | Young Adult | Antibodies, Monoclonal, Humanized | Cord Blood Stem Cell Transplantation - adverse effects | Antineoplastic Agents - adverse effects | Dyskeratosis Congenita - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Pulmonary Fibrosis - etiology | Vidarabine - adverse effects | Vidarabine - analogs & derivatives | Alemtuzumab | Antibodies, Neoplasm - administration & dosage | Vidarabine - therapeutic use | Combined Modality Therapy - adverse effects | Dyskeratosis Congenita - physiopathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Pulmonary Fibrosis - prevention & control | Bone Marrow Transplantation - adverse effects | Vidarabine - administration & dosage | Antibodies, Neoplasm - adverse effects | Epithelial cells | Patient outcomes | Abnormalities | Physiological aspects | Development and progression | Transplantation | Hematopoietic stem cells | Risk factors
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 9, pp. 1216 - 1226
Abstract Background Live vaccines are generally contraindicated on immunosuppressive therapy due to safety concerns. However, data are limited to corroborate... 
Allergy and Immunology | Live vaccine | Bone-marrow transplantation | Solid organ transplantation | Immunosuppressive medication | Immune-mediated inflammatory disease | MEDICINE, RESEARCH & EXPERIMENTAL | RUBELLA VACCINATION | ATTENUATED VARICELLA VACCINE | JUVENILE IDIOPATHIC ARTHRITIS | IMMUNOLOGY | YELLOW-FEVER VACCINATION | PEDIATRIC LIVER | ZOSTER-VIRUS | MEASLES VACCINATION | MULTIPLE-SCLEROSIS | LIVING DONOR | RHEUMATIC-DISEASES | Yellow Fever Vaccine - administration & dosage | Humans | Immunosuppressive Agents - therapeutic use | Vaccination | Infant | Male | Organ Transplantation | Mumps - prevention & control | Vaccines, Combined - administration & dosage | Inflammation - drug therapy | Bone Marrow Transplantation | Observational Studies as Topic | Female | Measles - prevention & control | Chickenpox Vaccine - adverse effects | Yellow Fever Vaccine - adverse effects | Immune System Diseases - drug therapy | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox - prevention & control | Chickenpox Vaccine - administration & dosage | Measles-Mumps-Rubella Vaccine - adverse effects | Rubella - prevention & control | Randomized Controlled Trials as Topic | Pregnancy | Vaccines, Combined - adverse effects | Vaccines, Attenuated - adverse effects | Yellow Fever | Transplantation of organs, tissues, etc | Clinical trials | Bone marrow | Transplantation | Research | Care and treatment | Multiple sclerosis | Systemic lupus erythematosus | Smallpox | Rubella | Transplants & implants | Subject heading schemes | Leukemia | Chicken pox | Rheumatic diseases | Viruses | Arthritis | Infections | Typhoid | Patients | Inflammatory diseases | Studies | Animal vaccines | Infectious diseases | Poliomyelitis | Measles | Lymphomas | Mumps
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer
Journal Article
Circulation Research, ISSN 0009-7330, 01/2013, Volume 112, Issue 1, pp. 165 - 173
RATIONALE:CD34 transplantation in dilated cardiomyopathy was associated with short-term improvement in left ventricular ejection fraction and exercise... 
heart failure | CYTOKINES | CARDIAC & CARDIOVASCULAR SYSTEMS | CD34(+) cells | bone marrow cells | BONE-MARROW | HEART-FAILURE | granulocyte colony-stimulating factor mobilization | TRIAL | ENDOTHELIAL PROGENITOR CELLS | DISEASES | ACUTE MYOCARDIAL-INFARCTION | IMPROVEMENT | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | dilated cardiomyopathy | Multivariate Analysis | Stem Cells - immunology | Cardiomyopathy, Dilated - pathology | Antigens, CD34 - metabolism | Myocardium - immunology | Follow-Up Studies | Ventricular Function, Left | Cardiomyopathy, Dilated - surgery | Humans | Middle Aged | Tumor Necrosis Factor-alpha - blood | Male | Cause of Death | Recovery of Function | Cell Tracking | Myocardial Perfusion Imaging | Exercise Test | Time Factors | Interleukin-6 - blood | Peptide Fragments - blood | Cardiomyopathy, Dilated - diagnosis | Female | Slovenia | Stem Cell Transplantation - mortality | Cardiomyopathy, Dilated - mortality | Natriuretic Peptide, Brain - blood | Biomarkers - metabolism | Coronary Circulation | Echocardiography | Cardiomyopathy, Dilated - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Myocardium - pathology | Treatment Outcome | California | Chi-Square Distribution | Stroke Volume | Cardiomyopathy, Dilated - physiopathology | Texas | Cardiomyopathy, Dilated - immunology | Exercise Tolerance | Cell Movement | Injections, Intra-Arterial | Stem Cell Transplantation - adverse effects
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 14, pp. 1598 - 1605
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 653 - 660
Journal Article
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2018, Volume 24, Issue 1, pp. 133 - 141
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 26, pp. 3141 - 3149
Purpose Related donor haploidentical hematopoietic cell transplantation (Haplo-HCT) using post-transplantation cyclophosphamide (PT-Cy) is increasingly used in... 
DISEASE RISK INDEX | ALLOGENEIC TRANSPLANTATION | HODGKINS-LYMPHOMA | ONCOLOGY | BONE-MARROW | UNRELATED DONORS | IDENTICAL SIBLINGS | PERIPHERAL-BLOOD | UMBILICAL-CORD BLOOD | STEM-CELL TRANSPLANTATION | DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE | Lymphoma - surgery | Multivariate Analysis | Recurrence | Cyclophosphamide - administration & dosage | Humans | Middle Aged | Male | HLA Antigens - genetics | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - adverse effects | Graft vs Host Disease - immunology | Lymphoma - mortality | Transplantation Conditioning - mortality | Young Adult | Haploidy | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Registries | Transplantation Conditioning - adverse effects | Transplantation Conditioning - methods | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Siblings | Calcineurin Inhibitors - administration & dosage | Histocompatibility Testing | Graft Rejection - prevention & control | Risk Factors | Lymphoma - immunology | Proportional Hazards Models | HLA Antigens - immunology | Lymphoma - genetics | Treatment Outcome | Disease-Free Survival | Adolescent | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Graft Rejection - immunology | Hematopoietic Stem Cell Transplantation - methods | Tissue Donors | Graft Survival - drug effects | Histocompatibility | Bone2 | ORIGINAL REPORTS
Journal Article